Post immunization COVID-19 disease – Docwire News

This article was originally published here

J Family Med Prim Care. 2022 Apr;11(4):1555-1557. doi: 10.4103/jfmpc.jfmpc_1975_21. Epub 2022 Mar 18.

ABSTRACT

One hundred and two patients reported to peripheral hospital, of these 73 (77%) and 23 (95%) suffered from COVID-19 disease, were immunized as per availability of Covishield 78 (77%) and Covaxin 24 (23%), respectively. Of these, three died (3%). Inflammatory markers were raised in Covishield vs. Covaxin 26 (36%) vs. 7 (31%), 46 (63%) vs. 8 (35%), 57 (78%) vs. 14 (61%), 29 (40%) vs. (73%), C-reactive proteins and serum ferritin, and positive for COVID-19 antigen and RTPCR and COVID-19 pneumonia, respectively. Irrespective of immunization status of victim with symptoms should be investigated for possibility of severe acute respiratory syndrome COVID-beta 2 (SARS-CoV-2) virus infection. These findings confirmed the need for a Booster dose of COVID-19 vaccination.

PMID:35516695 | PMC:PMC9067203 | DOI:10.4103/jfmpc.jfmpc_1975_21


Read more here: Source link